W. Petty

561 total citations
14 papers, 375 citations indexed

About

W. Petty is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, W. Petty has authored 14 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in W. Petty's work include Lung Cancer Research Studies (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Lung Cancer Diagnosis and Treatment (3 papers). W. Petty is often cited by papers focused on Lung Cancer Research Studies (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Lung Cancer Diagnosis and Treatment (3 papers). W. Petty collaborates with scholars based in United States, United Kingdom and China. W. Petty's co-authors include Nancy Upton, James S. Wallace, John D. Martin, Antonius A. Miller, Stacey S. O’Neill, Boris Pasche, Janet A. Tooze, Heidi D. Klepin, Ajeet Gajra and Jimmy Ruiz and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

W. Petty

13 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
W. Petty United States	8	136	133	80	74	67	14	375
Lauren Clarke United States	13	135 1.0×	486 3.7×	12 0.1×	175 2.4×	32 0.5×	18	775
Hideki Kanda Japan	15	214 1.6×	114 0.9×	140 1.8×	54 0.7×	25 0.4×	73	693
Young-Kyu Park South Korea	11	292 2.1×	60 0.5×	199 2.5×	26 0.4×	18 0.3×	36	773
Ross Jennens Australia	15	221 1.6×	335 2.5×	10 0.1×	82 1.1×	4 0.1×	45	624
Xiaoqian Zhang China	14	39 0.3×	83 0.6×	125 1.6×	87 1.2×	4 0.1×	19	515
Yu Kyung Lee South Korea	8	21 0.2×	143 1.1×	45 0.6×	71 1.0×	21 0.3×	22	315
Alex Mutebi United States	13	180 1.3×	108 0.8×	10 0.1×	179 2.4×	5 0.1×	51	615
Núria Puig Spain	11	54 0.4×	10 0.1×	15 0.2×	41 0.6×	35 0.5×	35	311
Jackie Johnson Australia	11	33 0.2×	85 0.6×	20 0.3×	49 0.7×	6 0.1×	44	460
Carlos Shimizu Japan	12	64 0.5×	179 1.3×	10 0.1×	207 2.8×	7 0.1×	50	513

Countries citing papers authored by W. Petty

Since Specialization

Citations

This map shows the geographic impact of W. Petty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Petty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Petty more than expected).

Fields of papers citing papers by W. Petty

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Petty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Petty. The network helps show where W. Petty may publish in the future.

Co-authorship network of co-authors of W. Petty

This figure shows the co-authorship network connecting the top 25 collaborators of W. Petty. A scholar is included among the top collaborators of W. Petty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Petty. W. Petty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Danhauer, Suzanne C., Emily V. Dressler, W. Mark Brown, et al.. (2023). Reducing Anxiety and Dyspnea via Device-Guided Breathing (RELAX): A Multi-Site Feasibility Study in Post-Treatment Lung Cancer Survivors at Community Cancer Clinics (WF-01213). Integrative Cancer Therapies. 22. 1563479542–1563479542.

Bogart, Jeffrey A., Xiaofei Wang, Gregory A. Masters, et al.. (2023). High-Dose Once-Daily Thoracic Radiotherapy in Limited-Stage Small-Cell Lung Cancer: CALGB 30610 (Alliance)/RTOG 0538. Journal of Clinical Oncology. 41(13). 2394–2402. 43 indexed citations

Awad, Mark M., Giacomo Pelizzari, James Stevenson, et al.. (2022). 989P Sotorasib in advanced KRAS p.G12C-mutated non-small cell lung cancer (NSCLC): Safety and efficacy data from the global expanded access program (EAP). Annals of Oncology. 33. S1005–S1005. 1 indexed citations

Ganti, Apar Kishor, Amylou C. Dueck, Briant Fruth, et al.. (2022). Comparison of quality of life in patients randomized to high-dose once daily (QD) thoracic radiotherapy (TRT) with standard twice daily (BID) TRT in limited stage small cell lung cancer (LS-SCLC) on CALGB 30610 (Alliance, Sub-study CALGB 70702).. Journal of Clinical Oncology. 40(16_suppl). 8504–8504. 2 indexed citations

Chang, Antao, Liang Liu, Dan Wu, et al.. (2021). Recruitment of KMT2C/MLL3 to DNA Damage Sites Mediates DNA Damage Responses and Regulates PARP Inhibitor Sensitivity in Cancer. Cancer Research. 81(12). 3358–3373. 39 indexed citations

Ruiz, Jimmy, Antonius A. Miller, Janet A. Tooze, et al.. (2018). Frailty assessment predicts toxicity during first cycle chemotherapy for advanced lung cancer regardless of chronologic age. Journal of Geriatric Oncology. 10(1). 48–54. 51 indexed citations

Yang, Mei, M. Elizabeth Forbes, Rhonda L. Bitting, et al.. (2017). Incorporating blood-based liquid biopsy information into cancer staging: time for a TNMB system?. Annals of Oncology. 29(2). 311–323. 72 indexed citations

Ruiz, Jimmy, Antonius A. Miller, Janet A. Tooze, et al.. (2016). Association of self-reported physical activity with survival among patients with advanced non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 34(15_suppl). e20664–e20664. 1 indexed citations

Lucas, John T., M. Soike, A. William Blackstock, et al.. (2014). An Evaluation of Toxicity Using Accumulated Total Dose Based on EQD2 for Thoracic Reirradiation Incorporating at Least 1 Course of SBRT. International Journal of Radiation Oncology*Biology*Physics. 90(1). S640–S641. 5 indexed citations

10.

Lewis, Jennifer A., W. Petty, James E. Peacock, et al.. (2014). Hemolytic anemia in two patients with glioblastoma multiforme: A possible interaction between vorinostat and dapsone. Journal of Oncology Pharmacy Practice. 21(3). 220–223. 7 indexed citations

11.

Kuremsky, Jeffrey G., James J. Urbanic, W. Petty, et al.. (2013). Tumor Histology Predicts Patterns of Failure and Survival in Patients With Brain Metastases From Lung Cancer Treated With Gamma Knife Radiosurgery. Neurosurgery. 73(4). 641–647. 43 indexed citations

12.

Martin, John D., W. Petty, & James S. Wallace. (2009). Shareholder Value Maximization—Is There a Role for Corporate Social Responsibility?. Journal of applied corporate finance. 21(2). 110–118. 40 indexed citations

13.

Hughes, Andrew, Mary O’Brien, David J. Dunlop, et al.. (2007). Phase I dose escalation pharmacokinetic study of erlotinib after failure of prior chemotherapy in patients with advanced NSCLC who continue to smoke. Journal of Clinical Oncology. 25(18_suppl). 3597–3597. 2 indexed citations

14.

Upton, Nancy & W. Petty. (2000). Venture capital investment and US family business. Venture Capital. 2(1). 27–39. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact